SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as community members aggressively debate whether the token is primed for a new all-time high or if it is entering a period of exhaustion. Bullish traders are actively calling for others to hold through dips and push for higher volume, while skeptics warn of potential rug pulls and shift their attention to emerging meme coins.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing significant volatility and trending momentum as investors closely monitor upcoming blockchain upgrades and potential token burn events. The community remains deeply divided, with many traders speculating on a supply shock and potential price recovery while skeptics warn of pump-and-dump risks.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is trending due to excitement surrounding its electro-optic polymer technology, with investors actively discussing potential integration into data centers and high-speed AI infrastructure through partnerships. The community remains highly focused on monitoring for commercialization catalysts and significant contract announcements, while debating the stock's valuation as it experiences increased trading volume and volatility.

MEME COIN: $ROAR is the OG token. Est. Sept '22. Inspired by The Roaring Kitty Who Inspired other to fight against wall street through Game Stop.  We Are  100% community-owned.  LP burnt.  Contract Renounced  Ready to Moon like $GME &amp; $AMC?

Roaring Kitty

The $ROAR token is seeing intense community-driven momentum as investors draw parallels between its community-led project model and the broader GameStop market sentiment. Discussions are dominated by speculation regarding potential exchange listings and the ongoing strength of the Roaring Kitty narrative, with holders emphasizing the project's decentralized, community-owned structure.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is generating strong community interest driven by its position as a key infrastructure layer for AI-integrated blockchain applications and its rising utility in cross-chain intents. Traders are actively discussing the protocol's fundamental strength and price compression as a potential setup for an upward breakout.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following the announcement of a preliminary Phase 3 trial design for its CAD-1005 program for Heparin-Induced Thrombocytopenia, marking a key milestone after end-of-Phase 2 FDA meetings. While supporters point to the potential of its cardiovascular pipeline and Orphan Drug designations as catalysts, community sentiment remains deeply divided as critics raise concerns regarding consistent bot-driven spam and the company's historical reliance on dilutive capital raises.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as the community maintains a patient, long-term outlook, frequently discussing the project's 'move-to-earn' utility and potential for a future breakout. Despite recent downward pressure, many supporters are actively accumulating while highlighting their commitment to the ecosystem's long-term growth and fitness-focused mission.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is currently a focal point for investors as the company navigates a critical FDA appeal process for its spinocerebellar ataxia therapy, with the community actively speculating on the impact of recent leadership changes at the FDA on potential drug re-reviews. Discussions are dominated by the search for a new path forward following a prior rejection, balanced against strong institutional positioning and institutional conviction that the company's broader pipeline remains significantly undervalued.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Equity Premium Income ETF

JPMorgan Equity Premium Income ETF

The JPMorgan Equity Premium Income ETF ($JEPI) remains a central focus for income-oriented investors, with recent community sentiment driven by its ability to provide monthly cash flow distributions amid broader market volatility. Investors are actively discussing the strategy's utility as a portfolio stabilizer and income generator, often comparing it to $JEPQ and other derivative-income funds to evaluate trade-offs between yield, tax treatment, and capital preservation.

VeChain, founded in 2015, is a sustainability-focused blockchain driving mass adoption of Web3. Its energy-efficient VeChainThor chain delivers fast, low-cost transactions, making blockchain accessible to millions worldwide. With partnerships including UFC, BCG, and Walmart, and over 2 million active users on VeBetter-powered apps, VeChain is proving real-world impact at scale.  In 2024, the VeChain Renaissance upgrade was launched, introducing Ethereum compatibility, dPoS consensus, and dynamic gas fees. It cut VTHO inflation and introduced StarGate NFT staking, where users lock VET to mint transferable NFTs that earn VTHO, can be delegated to validators, and serve as governance instruments. The upgrade also added new eco node tiers, lowering entry barriers while keeping rewards across higher staking levels.  By combining adoption, upgraded tokenomics, and inclusive staking, VeChain is positioning itself as a leading blockchain where usage, growth, and rewards fuel long-term value creation.

Vechain

VeChain is trending as investors debate the project's long-term utility against its recent lackluster price performance and declining market cap ranking. Community discussion is sharply divided between believers accumulating tokens in anticipation of network upgrades and long-term ecosystem development, and vocal skeptics frustrated by the lack of upward momentum compared to other altcoins.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Growth Stocks Worth Watching - April 29th

Ascendis Pharma A/S, Prologis, Teledyne Technologies, Hamilton Lane, and Tyra Biosciences are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow their revenues and earnings faster than the overall market, with...

Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the twelve ratings firms that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, ten have assigned a buy r...

Promising Growth Stocks To Follow Now - April 26th

Prologis, Teledyne Technologies, Hamilton Lane, Ascendis Pharma A/S, and Tyra Biosciences are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are...

Top Growth Stocks To Keep An Eye On - April 24th

Prologis, Teledyne Technologies, Hamilton Lane, Ascendis Pharma A/S, Tyra Biosciences, Canopy Growth, and Acadia Realty Trust are the seven Growth stocks to watch today, according to MarketBeat's...

Growth Stocks To Watch Now - April 19th

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Tyra Biosciences are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow revenue and earnings faster than the overall market, often due t...

Growth Stocks Worth Watching - April 18th

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Tyra Biosciences are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to increase revenue and earnings significantly faster than the overall m...

Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors

Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors PR Newswire CARLSBAD, Calif., April 17...

This Tyra Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

'Top Wall Street analysts changed outlook on top names. See all rating changes incl. upgrades, downgrades & initiations. TYRA rated Buy by analysts.'read more...

Growth Stocks To Watch Now - April 12th

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Tyra Biosciences, Acadia Realty Trust, and Hercules Capital are the seven Growth stocks to watch today, according to MarketBeat's...

JPMorgan Chase & Co. Trims Position in Tyra Biosciences, Inc. $TYRA

JPMorgan Chase & Co. lessened its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 27.9% during the third quarter, according to the company in its most recent filing with...

Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÅP, enables the rapid and precise refinement of structural design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA is developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family members, which are altered in approximately 7% of all cancers. The company was founded by Daniel Bensen and Todd Harris on August 2, 2018 and is headquartered in Carlsbad, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.59	--	--	N/A
Q4 '25	-$0.53	-$0.57	-7.24%	MISSED
Q3 '25	-$0.50	-$0.50	-0.50%	MISSED
Q2 '25	-$0.53	-$0.47	11.22%	BEAT
Q1 '25	-$0.49	-$0.47	3.25%	BEAT

TYRA
Tyra Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest TYRA News

TYRATyra Biosciences Inc